Clinical Trials Directory

Trials / Completed

CompletedNCT06379295

Coronary Artery Calcification Assessed on PET Scanner (PET : Positron Emission Tomography)

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Centre Hospitalier Régional d'Orléans · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Calcification artery calcium (CAC) scoring is a valuable tool for determining the risk of major adverse cardiac events. It was found that CAC can be quantitatively assessed, by manual scoring or using deep-learning, on low-dose non electrocardiogram-gated, contrast-enhanced or non-enhanced computed tomography (CT-scan) performed in association of PET acquisition, with a good agreement with standard scans. The purpose of this study is to determine the impact of a systematic coronary artery calcification evaluation in patients undergoing flourine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) imaging to improve primary prevention of cardiovascular diseases. A visual calcification artery calcium assessment will be made for each patient, dividing them into four groups: none, mild, moderate or heavy calcification artery calcium. When possible, a calcification artery calcium score will be computed. Each patient will complete a questionnaire to collect risk factors, history of cardiovascular diseases and medications.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireSelf-administered questionnaire to assess the participants risk factors, history of heart disease and medications.

Timeline

Start date
2024-06-06
Primary completion
2024-07-22
Completion
2024-07-22
First posted
2024-04-23
Last updated
2024-11-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06379295. Inclusion in this directory is not an endorsement.